Should I sell Panacea Biotec share?
Should I sell Panacea Biotec share?
A SELL signal was generated in Panacea Biotec….
Upside intraday target | 218.03 |
---|---|
Upside intraday target | 217.1 |
Upside short term target | 214.18 |
Upside mid term target | 227.73 |
Upside long term target | 285.98 |
What happened Panacea Biotec?
Panacea Biotec Pharma, a 100% subsidiary of Sputnik V Covid jab manufacturer Panacea Biotec, defaulted on payment of ₹114.67 crore including an interest component due on September 30.
Who are the promoters of Panacea Biotec?
presents the Promoter’s holding, FII’s holding, DII’s Holding, and Share holding by general public etc….PREMARKET.
Shareholding Pattern – Panacea Biotec Ltd. | ||
---|---|---|
NoOfShares | 61250746 | 100% |
Promoters | 45074866 | 73.59% |
ForeignInstitutions | 10 | 0% |
NBanksMutualFunds | 0 | 0% |
Is Panacea Biotec is a MNC company?
Panacea Biotec is a global generic and specialty pharmaceutical and vaccine maker registered in India with principal offices in New Delhi, Mumbai, and Lalru (near Chandigarh, India). Panacea Drugs Pvt. Ltd….Panacea Biotec.
Type | Public |
---|---|
Products | Pharmaceuticals, generic drugs, vaccine |
Website | www.panaceabiotec.com |
Who is the founder of Panacea Biotec?
Panacea Biotec
Type | Public |
---|---|
Founded | 1984 |
Headquarters | New Delhi, India |
Key people | Soshil Kumar (Executive Chairman of the Board), Dr. Rajesh Jain (Managing Director), Sandeep Jain (Joint Managing Director) |
Products | Pharmaceuticals, generic drugs, vaccine |
Who is owner of Serum Institute of India?
Poonawalla Investments & Industries Pvt. Ltd.
Serum Institute of India/Parent organizations